Thermo Fisher Scientific, The World Leader In Serving Science, Today Announced The Launch Of The Taqpath Enteric Bacterial Select Panel, A Ce-Ivd Marked Panel Designed To Detect Common Gastrointestinal (Gi) Bacteria And Help Enable Clinicians To Identify The Root Cause Of An Infection And Administer The Most Appropriate Treatment To Their Patients More Quickly. The Panel Was Validated And Registered Under Ivdd In May 2022.The New Test Leverages Polymerase Chain Reaction (Pcr) Technology To Analyze Stool Samples For A Range Of Common Gi Bacteria, Including Salmonella Spp.; Shigella Spp./Enteroinvasive E. Coli (Eiec); Campylobacter Jejuni, Campylobacter Coli, And Campylobacter Upsaliensis. It Is Able To Reliably Return Results In About Two Hours With More Than 98 Percent Sensitivity And Specificity. In Comparison, Culturing Samples In A Laboratory Can Take Up To Two Weeks To Deliver Results.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!